Skip to content

Self Mobility Improvement in the Elderly by Counteracting Falls (SMILING)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00877721
Enrollment
30
Registered
2009-04-08
Start date
2010-04-30
Completion date
2010-07-31
Last updated
2010-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Falls

Keywords

Postural Control, Gait, Falls, Elderly, Old adults (65 years old and older) with low risk of falls

Brief summary

Experimental design overview: The proposed project is a prospective experimental study design. Independent old adults (age 65 years old and older) who suffer from minor balance problems willing to participate in the study will be tested with well-established measuring techniques of balance and gait before and 4 weeks after balance training program using the Self Mobility Improvement in the Elderly by Counteracting Falls system (SMILING system). The study design is randomized clinical trial (RCT), cross over, single blinded study design where 30 subjects will randomly be allocated into experimental or control groups that will switch groups after 4 weeks of intervention. Random sequence generation will be performed by a staff member who will not interact with subjects during the balance-testing sessions. Subjects will be informed that they are to be randomly assigned to one of the two groups, both receiving gait training program. The staff member who administers the training programs will be the only member of the research team aware of the subjects' group allocations. A 'blinded' research assistant will administer the balance tests and will perform any data processing that involves subjective judgments. Scripts will be used during testing to ensure that all subjects receive the same instructions. Testing session between two training periods (T1) will take one week.

Interventions

DEVICESelf Mobility Improvement in the eLderly by using the SMILING system

The effect of treatment with the SMILING system on postural stability and gait of elderly individuals will be measured using RCT cross over study design

Sponsors

European Union
CollaboratorOTHER
Soroka University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

The inclusion criteria are: Self-reported information 1. age ≥ 65 years, 2. able to walk at least 20 meters independently, i.e., without personal assistance and without an assistive device, except for a single point cane 3. one or more falls in the previous year (falls during sport activities excluded). Standardized physical and cognitive functional tests 1. Tinetti's POMA score below 26 (strictly) 2. MMSE test with score ≥ 24 3. GDS test with score \<10 The

Exclusion criteria

are: 1. Self-reported information 2. age \< 65 years 3. inability to walk 20 meters safely (self-report) or walk with personal assistance or with an assistive device (except single point cane for fallers) 4. inability to recall fall status in the previous year 5. severe visual impairment (e.g., impaired ability to read, watch TV, or drive a car) 6. severe hearing impairment (e.g., unable to follow a conversation, to use a phone) 7. Standardized physical and cognitive functional tests 8. Tinetti's POMA score less than 19 9. MMSE score \< 24 10. GDS test with score ≥ 10 11. Medical conditions (filled in by the family doctor of the subject) 12. wearing a pacemaker, a cardiac defibrillator or any other electronic implant 13. severe gait impairment precluding safe walking over 20 meters due to: 14. focal lower limb muscle weakness or palsy (e.g., unable to raise leg/foot from floor) 15. neurological diseases, including diseases such as severe Parkinson's disease, Multiple Sclerosis, status post stroke with hemi-syndroma, cervical or lumbar stenosis with compression myelopathy, polyneuropathy with severe proprioceptive impairment, Menier 16. severe cardiovascular disease 17. foot problems, lower limb amputation or joint arthrodesis 18. terminal diseases (defined as estimated life expectancy of less than 6 months).

Design outcomes

Primary

MeasureTime frame
gait analysistime 1: pre test; time 2 post test (4 weeks after pre test) and time 3 follow up (8 weeks after pre test)

Secondary

MeasureTime frame
Tinetti's performance-oriented mobility assessment (POMA score), CODEX test, GDS testtime 1: pre test; time 2 post test (4 weeks after pre test) and time 3 follow up (8 weeks after pre test)
CODEX testtime 1: pre test; time 2 post test (4 weeks after pre test) and time 3 follow up (8 weeks after pre test)
GDS testtime 1: pre test; time 2 post test (4 weeks after pre test) and time 3 follow up (8 weeks after pre test)

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026